Item 1A. Risk Factors
4K characters. Original on sec.gov ·
Item 1A. Risk Factors
The discussion of our business and operations should be read together with the risk factors contained in our Annual Report on Form 10-K for the fiscal year ended June 30, 2026, or the Annual Report, which was filed with the SEC and describe various material risks and uncertainties to which we are or may become subject. As of September 30, 2026, there have been no material changes to such risk factors.
Item 2 Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities
Purchases of equity securities. The following table summarizes our purchases of common stock for the three months ended September 30, 2026:
| Period | Total Number of Shares Purchased**(1)** | Average Price Paid per Share (USD) | Total Number of Shares Purchased as Part of Publicly Announced Programs**(2)** | Maximum Number of Shares that May Yet Be Purchased Under the Program | ||||||||||||||||||||||
| July 1 - 31, 2026 | — | $ | — | 46,798,043 | 7,917,970 | |||||||||||||||||||||
| August 1 - 31, 2026 | 1,834,183 | 232.40 | 48,632,226 | 6,083,787 | ||||||||||||||||||||||
| September 1 - 30, 2026 | 1,809,319 | 232.17 | 50,441,545 | 4,274,468 | ||||||||||||||||||||||
| Total | 3,643,502 | $ | 232.29 | 50,441,545 | 4,274,468 |
1.No shares during the period were repurchased other than pursuant to a publicly announced plan or program.
2.Represents the aggregate number of shares purchased under our 2014 Program, under which 20.0 million shares have been approved for repurchase.
On February 21, 2014, our board of directors approved our current share repurchase program, authorizing us to acquire up to an aggregate of 20 million shares of our common stock. The program allows us to repurchase shares of our common stock from time to time for cash in the open market, or in negotiated or block transactions, as market and business conditions warrant and subject to applicable legal requirements. The share repurchase program may be accelerated, suspended, delayed or discontinued at any time at the discretion of our board of directors. All share repurchases after February 21, 2014 have been executed under this program. Since approval of the share repurchase program in 2014 through September 30, 2026, we have repurchased approximately 15.7 million shares under this repurchase program for an aggregate of $2.4 billion.
On August 31, 2026, we entered into an accelerated share repurchase agreement, or the ASR Agreement, to repurchase $450 million of our common stock. Pursuant to the ASR Agreement, we paid $450 million and received an initial delivery of 1.6 million shares during the three months ended September 30, 2026, representing an estimated 80 percent of the shares to be purchased under the ASR Agreement based on the $230.87 closing price of our common stock on September 2, 2026. Final settlement of the ASR Agreement is expected to occur no later than December 29, 2026, and will be based on a discount to the volume-weighted average price per share of our common stock over the term of the ASR Agreement.
Item 3 Defaults Upon Senior Securities
None
| PART II – OTHER INFORMATION | Item 1-6 |
RESMED INC. AND SUBSIDIARIES
Item 4 Mine Safety Disclosures
None
Previous: Item 4. Controls and Procedures · Next: Item 5. Other Information